1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab usage are associated with reduced objective fractures successful postmenopausal patients with osteoporosis.
2. Abaloparatide and teriparatide whitethorn summation the hazard of withdrawal-associated adverse events.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Osteoporosis results successful bony weakness and accrued susceptibility to fractures. By the modular definition, astir 20% of United States pistillate adults older than property 50 years were estimated to person osteoporosis successful 2018, up from 14% a decennary earlier, on with much than 4% of males successful this property group. However, determination is simply a spread successful cognition arsenic to knowing the treatments to forestall fractures successful those with debased bony wide oregon osteoporosis. Overall, this survey recovered that bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab importantly reduced objective fractures and radiographic vertebral fractures for much than 2 years. This survey was constricted by fewer studies that examined participants with debased bony mass, males, oregon Black-identifying persons, sequential therapy, oregon attraction beyond 3 years. Nevertheless, these study’s findings are significant, arsenic they show that respective medications importantly reduced objective fractures successful postmenopausal females with osteoporosis. However, immoderate medications whitethorn summation withdrawals owed to adverse effects.
Click to work the survey successful AIM
In-Depth [meta-analysis]: This surviving systematic reappraisal and web meta-analysis included English-language randomized controlled trials (RCTs) successful pistillate oregon antheral adults with debased bony wide oregon osteoporosis not owed to a secondary origin (for example, glucocorticoid therapy) comparing 1 oregon much pharmacologic interventions of involvement to each different oregon placebo. Included interventions were bisphosphonates (alendronate, ibandronate, risedronate, and zoledronate), parathyroid hormones (PTHs; abaloparatide and teriparatide), receptor activator of atomic origin κB ligand inhibitors (denosumab), selective estrogen receptor modulators (SERMs; raloxifene and bazedoxifene), and sclerostin inhibitors (romosozumab). Also included successful the reappraisal were RCTs reporting fractures arsenic efficacy outcomes (rather than information outcomes) with 12 months oregon much of follow-up. The superior result measured was survey characteristics and outcomes data, including hip, vertebral (clinical oregon radiological), objective nonvertebral (symptomatic fractures astatine sites beyond the vertebrae, which typically excluded insignificant fractures specified arsenic those of the digits), and immoderate objective fractures (a composite of objective vertebral and nonvertebral fractures). Outcomes successful the superior investigation were assessed via pairwise meta-analyses utilizing a random effects model. Based connected the superior analysis, bisphosphonates and denosumab reduced hip, clinical, and radiographic objective fractures successful postmenopausal pistillate adults with osteoporosis. Bisphosphonates for 36 months oregon much were recovered to summation the hazard for atypical femoral fractures and osteonecrosis of the jaw, but the implicit risks were low. Abaloparatide and teriparatide reduced objective and radiographic vertebral fractures but accrued the hazard for withdrawals owed to adverse events. Overall, this survey recovered that respective medications, including bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduced objective fractures successful postmenopausal pistillate adults with osteoporosis.
Image: PD
©2023 2 Minute Medicine, Inc. All rights reserved. No works whitethorn beryllium reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire astir licensing here. No nonfiction should beryllium construed arsenic aesculapian proposal and is not intended arsenic specified by the authors oregon by 2 Minute Medicine, Inc.
English (US)